Our People
The ACELYRIN Team
We are led by experienced biopharma executives with exceptional track records of building strong, innovative and diverse teams across the healthcare industry.
Mina Kim
Chief Executive Officer
Kelly Chow
Chief People Officer
Ken Lock
Chief Commercial Officer
Shephard (Shep) Mpofu, MD, MRCP, FRCP
Chief Medical Officer
Amar Murugan
Chief Legal Officer
Patricia Turney
Chief Technical Operations Officer
Latest Press Releases
ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
Press Release
ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
Read more ACELYRIN, INC. to Host Virtual Investor Event to Share new Phase 2 Data and Phase 3 Program Design for Subcutaneous Lonigutamab
Press Release
ACELYRIN, INC. to Host Virtual Investor Event to Share new Phase 2 Data and Phase 3 Program Design for Subcutaneous Lonigutamab
Read more 